chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Burning and stabbing pains in ribs at left back at spine. Went to my primary physician on 9/10/18 but he found nothing. Went to clinic on 9/20/18 because pain was worse. They x-rayed my ribs on left side, but found no problems. The nurse practitioner mentioned that my symptoms were like those who had shingles but I had no rash. Went back to clinic on 10/25/18 and the N.P. said I had "Internal Shingles" and put me on Valacyclovir and gabapentin. She said I had most probably had it since 9-10-18, when I first complained. I got the original shingles shot (ZOSTAVAX) on 7/19/11 and had no adverse reaction. This SHINGRIX shot caused my arm to swell, turn very red, had fever, and I couldn't raise my left arm above my breast. These symptoms lasted 4 days. This was the 1st of two doses. Will not take the 2nd dose. I was told "Internal Shingles" is uncommon, which is why they could not diagnose me when I first gave them my pain symptoms. I had none of the typical "rash" that always indicates you have shingles.
Administered vaccine from primary Moderna series instead of bivalent. This provider attempted to reach patient to notify them of the medical error that occurred but was unsuccessful. At the time of administration, patient tolerated the vaccine well and denied any immediate adverse effects.
A patient got her second dose of the Moderna vaccine on 1/4/22 around 4 pm at the pharmacy. The patient called the pharmacy in the morning and said that she woke up with the typical side effects of the booster (muscle aches and tiredness), but also had swelling in her lips and eyes. She said that it started early in the morning and she does not feel any pain but her lips feel a little numb/tingly. She said there is puffiness but no redness. She patient reported no other abnormal side effects and stated that it is just the puffiness/swelling of the eyes and lips that concerned her. She said she isn't having any trouble breathing, rash, dizziness, fast heartbeat, or swelling in the throat. The patient reported no other foods or triggers in the past 24 hours that may have caused the effect. The patient was advised that she should contact her doctor directly for further guidance and monitoring. She was advised that if her symptoms get any worse resembling those of an allergic reaction, she should seek medical help immediately. The patient's doctor was contacted by the pharmacy as well to report the patient's symptoms.
Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/3/2023 Discharge Date: 3/6/23  PRESENTING PROBLEM: Acute deep vein thrombosis (DVT) of femoral vein of left lower extremity (HCC) [I82.412] Acute deep vein thrombosis (DVT) of proximal vein of left lower extremity (HCC) [I82.4Y2]   HOSPITAL COURSE: Very pleasant 68-year-old woman with heterozygous factor 5 Leiden, she had COVID 4 weeks ago, went on a 2500mi road trip and returned 2 days ago.  She presented with acute left leg swelling and calf pain found to have a extensive left lower extremity DVT.   She has never had a DVT herself.  She denies any chest pain, palpitations or dyspnea on exertion.  She has never had surgery to the lower extremities or prior vein problems.  She does take an aspirin daily due to her history of heterozygous factor 5 Leiden.  She was on estrogen patch for menopause up until December 2022.  Most of her relatives have had DVTs in the past.   In the emergency department, she was afebrile, heart rate 77, blood pressure 150/93, 100% on room air.  DVT duplex was obtained which showed a extensive left lower extremity DVT extending to the left iliac vein. She will be admitted for IR intervention of extensive DVT.   She underwent mechanical thrombectomy with stent placement with IR during her hospital stay. She was continued with hep gtt surrounding the procedure. She was then started on plavix and Eliquis prior to discharge with plans to continue Eliquis x 1 year and plavix x 6 weeks per recs. She was discharged home in stable conditions with plans to f/u with her PCP to discuss med changes and elevated BP
Pt devel discoloration & swelling of legs & feet approx 5min p/receiving immun;
Heart pain/discomfort; inflammation of heart tissue; Heart pain/discomfort; chest discomfort; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Jul2021 (Lot number: FA6780) at the age of 31 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing); "asthma" (unspecified if ongoing); "Shell fish" (unspecified if ongoing); "Covid-19" (unspecified if ongoing). Concomitant medication(s) included: EDARBYCLOR. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3180), administration date: 10Aug2021, when the patient was 31 years old, for COVID-19 immunization. The following information was reported: ANGINA PECTORIS (medically significant), CARDIAC DISCOMFORT (medically significant) all with onset 18Jul2021, outcome "not recovered" and all described as "Heart pain/discomfort"; MYOCARDITIS (medically significant) with onset 18Jul2021, outcome "not recovered", described as "inflammation of heart tissue"; CHEST DISCOMFORT (medically significant) with onset 18Jul2021, outcome "not recovered", described as "chest discomfort". The events "heart pain/discomfort", "heart pain/discomfort", "inflammation of heart tissue" and "chest discomfort" were evaluated at the physician office visit. Therapeutic measures were taken as a result of angina pectoris, cardiac discomfort, myocarditis, chest discomfort.
My entire left arm has been stiff and sore ever since injection. Pain has traveled from injection site down to my fingertips. Weeks later I am in moderate pain.
pt recvd vax;high fever up to 105; had cough, began rash on 26feb;to MD;swollen glands,sore throat,poor appetite;runny nose,loose stools, poor balance
A physician reported the occurrence of pertussis in a 10 month old male who was vaccinated with Infanrix for prophylaxis. The vaccine provider submitted a report directly to the local county health dept. The subject had no relevant medical history. He experienced no adverse events following previous immunizations. The subject received injections of Infanrix on 1/16/02 (527A2), 3/1/02 (527A2) and 5/1/02 (525A2). He also received injections of hep B vaccine (mnauf unk 1/16/02 and 3/1/02), IPOL (1/16/02, 3/1/02 and 5/1/02), Prevnar (1/16/02, 3/1/02 and 5/1/02), Hib (manuf unk 1/16/02, 3/1/02 and 5/1/02). Each injection of Infanrix was given in the same site as the Hib vaccine, rather than at separate sites as recommended. On 8/21/02, three months after the third injection of Infanrix, the subject developed a cough "for an extended time" and received unspecified treatment. On 8/26/02, the subject was seen in the local ER for what was thought to be reactive airway disease. A Bordatella parapertussis smear obtained on that date was positive. At the time of diagnosis, the subject was already receiving therapy with Augmentin for an incidental otitis media. The pertissus resolved after an unspecified period of time.
This spontaneous report as received from a nurse practitioner refers to a 68 years old female patient with penicillin allergy and no pertinent medical history. On 07-NOV-2012 the patient was vaccinated with ZOSTAVAX subcutaneously to prevent shingles. Dose was not provided. Product lot # was reported as H011050 (with expiry date of 05-SEP-2013). No other co-suspects were reported. Concomitant medications included atenolol, ZETIA, lisinopril, hydrochlorothiazide, glucosamine, metformin and diltiazem hydrochloride, all for unknown indications. In November 2012, 2 weeks after vaccination, the patient developed itchy rash all over her body and sought for medical attention. The rash started at the injection site of the patient's left arm and processed to both sides of the patient's body, from the neck down to the toes. It was noted that the rash was worse at the injection site compared to the rest of the patient's body. The patient received treatment with VALTREX and BENADRYL. The outcome of itchy rash all over the body was reported as not recovered/not resolved. No causality assessment was provided. Additional information has been requested.
Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 was taken out of freezer on 04/20/2022. Out of freezer expiration date 05/20/2022; Patient was given expired (4 days expired) Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 IM 0.25mL as a fourth dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given expired (4 days expired) Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 IM 0.25mL as a fourth dose) and PRODUCT STORAGE ERROR (Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 was taken out of freezer on 04/20/2022. Out of freezer expiration date 05/20/2022) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033K212A, 042L20A, 013M20A and 011F21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 24-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 24-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given expired (4 days expired) Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 IM 0.25mL as a fourth dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 was taken out of freezer on 04/20/2022. Out of freezer expiration date 05/20/2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was given expired (4 days expired) Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 IM 0.25mL as a fourth dose) and PRODUCT STORAGE ERROR (Moderna vaccine lot 033K212A manufacturer expiration date 05/20/2022 was taken out of freezer on 04/20/2022. Out of freezer expiration date 05/20/2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  There were 12 to 14 booster doses in 1 vial.  The vial did not undergo any temperature excursions.  Moderna vaccine lot 033K212A manufacturer expiration date was reported as 20 May 2022 and was taken out of freezer on 20 Apr 2022. Out of freezer expiration date was reported as 20 May 2022.  No treatment medication information provided.   This case was linked to MOD-2022-590546, MOD-2022-590542, MOD-2022-590544, MOD-2022-590553 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2022: Follow up received. Validity changed to valid case. Added secondary reporter. Patient initials, demographics, dosage regimen added, event verbatim and inarrative supplement updated.
Pt received the vaccine and after approximately 10 minutes, pt reported having a tingling sensation in her feet that was rising to her shins and up her body.  Patient started having severe tremors and rigidity in her upper and lower extremities.  Patient never lost consciousness but her responses were severely slowed. Her eyes were dilated and she never blinked as she clenched her teeth. Muscles in her hands and arms were extremely tight and rigid.  She never stopped breathing or lost total consciousness.   An ambulance was called and EMS presented after 20 minutes.  Patient became post ictal and started moving her head and body voluntarily.  She also was able to freely answer questions asked of her without delay.  EMS transported pt to the ED.
Information has been received from the pregnancy Registry for GARDASIL from a licensed practical nurse concerning a 19 year old female patient with no pertinent medical history or no known drug allergies, who on 08-SEP-2009 was vaccinated with the first dose of GARDASIL (Lot number 663453/0249Y) intramuscularly and on 10-NOV-2009 received the second dose of GARDASIL (Lot number 663453/0249Y). There was no concomitant medication. Nurse reported that after receiving 2 doses of GARDASIL is now pregnant. An ultrasound done on 20-JAN-2010 showed the patient was 19 weeks pregnant. The patient went to the emergency room (hospital unknown) on 18-JAN-2010 because of a urinary infection so as routine, the emergency room did a urine check that included a pregnancy test. The urine pregnancy test was positive. The LMP was on approximate 30-AUG-2009 and her EDD on 06-JUN-2010. Additional information has been requested.
Arm felt cold and slightly numb for about 30 minutes beginning about 5 minutes after receiving the injection.  The pharmacist asked me to stay for a longer monitoring period.  After 30 minutes the symptoms subsided and did not return.
Brought in by mom. Seen 8 days ago for 2 year well child visit. Usual vaccines given with Dtap and Flu vaccines given on L thigh. Left clinic in no distress. Mom noticed the next day the area on L thigh where vaccines were given becoming red and swollen, with erythema moving down thigh to lower leg. Brought to urgent care where child diagnosed with infection and placed on Cephalexin which he refused to take. Mom denies any fever and erythema has completely resolved. Mom states child taking excessively long naps in the afternoon since incident. Sleeps at usual nap time of 3pm and will sleep until 11 pm.
Itchy rash occurred after first dose on 12/21/21. Rash to arms, back and chest. Cleared up. After 2nd vaccine same rash but hasn't cleared.
Medical Assistant noticed the HPV vaccine was expired after the vaccine was administered. MD, Supervisor and Health Dept were notified.
DOSE 2 ONLY: Next morning, (today) awoke feeling tired and achy; Ocular Migraine 1:00 pm to 1:15ish pm today as well--has not resolved. No pain, just visual distortions, as usual; Still feeling tired/achy as I report this (2:15 pm)
This spontaneous report as received from a Physician Assistant refers to a patient of unknown age. The patient was vaccinated with ZOSTAVAX (route, dose and lot # were not reported). No other co-suspects were reported. No concomitant medications were reported. The physician Assistant administered a dose of ZOSTAVAX that had been improperly stored. The date administered of improperly stored ZOSTAVAX was unknown at the time of the call. No adverse event reported. The outcome of event was unknown. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Patient presented to the pharmacy with redness and swelling below the injection site. She had some discoloration/bruising at the injection site.
Pt C/O difficulty breathing, fever, headache, eyes hurt, sinuses acting up, rashes on chest during the  evening hours of 9/18 or 9/19
Patient fainted about 15 minutes after receiving vaccine. Sat up for a few minutes then vomited. Blood pressure was low ~60/40. EMT was called and pt was taken to hospital since blood pressure was still low.
2PM eyes red, mattered, burning, scratchy; chills/fever-q 2 hrs; nausea/vomiting/h/a, lethargy 12 hrs;
rash extending from shoulder to elbow - red, warm, itchy lack of energy - tired - slept all day as of 10/24 symptoms were subsiding
A non-serious spontaneous report of inadvertently given half dose of H1N1 LAIV was received from a nurse/health professional concerning a 31-year-old female. The patient's medical history and concomitant medications was not reported. On 27-Oct-2009, the patient was inadvertently given half dose of H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Approximately on 09-DEC-2012 reported as about 2 days ago the patient was vaccinated with a dose of ZOSTAVAX (lot number, route and dose were not reported). After vaccinationapproximately on 09-DEC-2012 the patient developed shingles like rash. The patient sought medical attention, the patient saw the physician). No treatment information was reported. The outcome of shingles like rash is not recovered/resolved. The relatedness for shingles like rash is unknown for ZOSTAVAX. Additional information has been requested.
Soon after the injection the shoulder became extremely painful--far more than typical with a shot. The pain did not subside or resolve. It remained very painful and I had limited range of motion for 6-8 weeks; then there was a slight diminishment. I had an ultrasound 2 months after injection and "significant bursitis" and a rotator cuff tear was discovered. The doctor thought it very likely that I was injected into the bursa, not the Deltoid. He prescribed Voltaren gel and there was a significant decrease in inflammation and pain, but it still has not completely resolved, almost 5 months later.
pt recv vax 1APR96 & JUN96 pt exp a negative titer;
Patient was administered 6 vaccinations that day she the record listed noted that DO NOT USE next to the Hep A vaccine. His records also listed that he was previously given 3 adult dosages of Hep B.  Patient was later recommended for speech and language evaluation by Dr. and treated for fluid in the middle ear. Patient underwent surgery and had tubes placed in his ear. He is now being treated for speech and language processing disorder and he has a significant fine and gross motor skill development receiving therapy in schools.  One of his legs is shorter than the other although he wasn?t born that way.
Patient  w/h/o afib, but was regular prior to the vaccine,  showed up to the hospital approx. 1 mo after their 2nd moderna vaccine w/afib w/RVR  and failed cardioversion.
Headache, Diarrhea, sore throat, abdominal pain, swollen hands and joints. Narrative:
Site of injection became swollen, red, hot to touch a few hours after injection.  Redness and heat spread to several inches and remained >24 hours.  Saw occupational health nurse and MD who provided zyrtec and pepcid to reduce histamine reaction.  48 later area is still red, swollen, and warm to touch but improving.
Patient is a 85 y.o. male patient of DO with history of HLD, GERD, COPD, Prostrate cancer, BPH, Anxiety and depression, mild cognitive impairment  presented to Hospital with cough, congestion, weakness .   Clinical Summary   COVID-19   - Symptoms began 12/9 - Positive test 12/15 - No supplemental oxygen requirement - Patient was given steroids while hospitalized - Patient did not receive remdesivir   Newly Diagnosed A Fib   - EF 45& - Rate control excellent on Toprol XL 50 mg daily - Eliquis 2.5 mg BID started   CKD stage 3   - I hel d off on starting losartan due to mild hyperkalemia
high blood pressure; both hands were contracting; both feet were contracting; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure) and JOINT CONTRACTURE (both feet were contracting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).    On 20-Jan-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (high blood pressure) and JOINT CONTRACTURE (both feet were contracting). At the time of the report, HYPERTENSION (high blood pressure) and JOINT CONTRACTURE (both feet were contracting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 188 mmHg high blood pressure.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
12 hours after administration. Fever approx. 102 F, headache, chills, diarrhea, cold symptoms.
Patient reports experiencing extreme discomfort in that arm, starting with soreness that developed into "inflammation". Patient describes inflammation as sensitivity to stimuli of previous injuries on entire right arm.
At 2am on 04/09/2021 I woke up with extreme muscle pain all over my body; That morning I woke up sweating; Weak/fatigue; Nauseated; Headache; That morning I woke up sweating and feeling lightheaded, extreme muscle pain, weak/fatigue, nauseated, headache and had a high heart rate and blood pressure. My heart rate was 109 and it is typically in the 60s or 70s.; That morning I woke up sweating and feeling lightheaded, extreme muscle pain, weak/fatigue, nauseated, headache and had a high heart rate and blood pressure. My blood pressure is typically low (around 104/55) and that morning it was 132/89.; Weak/fatigue; After receiving the first vaccine I was lightheaded; Metallic taste in my mouth. The metallic taste went away within the 15 minutes.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 18:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, after receiving the first vaccine the patient felt lightheaded and had a metallic taste in her mouth. The metallic taste went away within the 15 minutes. On 09Apr2021 at 02:00, the patient woke up with extreme muscle pain all over her body. That morning she woke up sweating and feeling lightheaded, extreme muscle pain, weak and fatigue, nauseated, headache and had a high heart rate and blood pressure. The headache that morning felt different from any other headache she had before, it felt like her eyes were going to pop and that was why she decided to check her blood pressure. Her blood pressure was typically low around 104/55 (units unspecified) and that morning it was 132/89 (units unspecified). Her heart rate was 109 (units unspecified) and it was typically in the 60's or 70's (units unspecified). Her body temperature was always normal. She stayed with these symptoms until 17Apr2021. The only side effect she was still feeling on the day of report was fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste was resolved on an unknown date in Apr2021, after a duration of 15 minutes; light-headed, muscle pain, sweating, weak, nauseated, headache, blood pressure of 132/89 (units unspecified), heart rate of 109 (units unspecified) was resolved on 17Apr2021; while that of fatigue was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.